SYMBIOSES DEVELOPPEMENT financials
A multi-period view of the public annual-account figures reported for SYMBIOSES DEVELOPPEMENT, with comparable measures and links to available source documents.
Company overviewRegistry number
0832213478
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for SYMBIOSES DEVELOPPEMENT
2025 versus 2024
- Operating line
- €32,125
- EBITDA
- €30,238
- Total assets
- €195,626
- Equity
- €27,499
+2.2%
+1.3%
-0.2%
+90.2%
EBITDA margin +94.1% · Equity ratio +14.1%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.